TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Plaque index values
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Gingival groove fluid examination
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of bacterial colony forming units (CFUs)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Neonatal Pain and Stress Rating
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time to first Rescue Analgesia
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of Participants Reporting Treatment-emergent Adverse Events
Endpoint domain: Adverse events/effects
Primary endpoint: Geometric Mean Titer (GMT) of SARS-CoV-2 Specific Neutralizing Antibody
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Seroconversion Rates of SARS-CoV-2 Specific Neutralizing Antibody
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Caries at restoration margin
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Hypertension rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Deregulation of blood proteins expression
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Deregulation of blood metabolites expression
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Social Memory Test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Engagement with the digital health-coaching platform
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Adoption of the digital platform
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Need for Postoperative ICU Admission
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Adverse events graded by CTCAE v5.0
Endpoint domain: Adverse events/effects
Primary endpoint: Seroconversion rates of the vaccination
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Seropositive rates after the vaccination
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Serum Urea and Sodium levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Attention task with spatial numbers
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Visuo-Constructional Ability task
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Working posture assessment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Child developmental outcome
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Degree of flexion and extension at wrist joint
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Degree of supination and pronation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Safety and tolerability of PVT201
Endpoint domain: Adverse events/effects
Primary endpoint: Detection rate of aggregated infections
Endpoint domain: Adverse events/effects
Primary endpoint: Severity of left ventricular myocardial inflammation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Extent of left ventricular fibrosis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Change in 24-hour Urinary pH
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change in 24-hour Urinary Citrate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Proportion of subjects maintaining hematologic recovery
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Change from baseline in ESSDAI
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change from baseline in ESSPRI
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Number of outpatient clinic visits
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Number of emergency medical visits
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Number of outpatient clinic visits for substance use disorder (SUD)
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Dilation & Evacuation (D&E) Operative time
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: active knee range of motion
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Optical Transparency
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Area under the curve (AUC) for pain intensity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of EC-confirmed CMV disease
Endpoint domain: Adverse events/effects
Primary endpoint: Cumulative number of liver-related clinical outcomes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in RV/LV ratio
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Intake of key dietary indicators
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Screen time
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Change in gut microbiome profile
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in numbness and tingling self-perceived by patients
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Change in degree of neuropathy according to QLQ-CIPN20 scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Change in Grade of toxicity of parestesias according to CTCAE v.5.0 scale
Endpoint domain: Adverse events/effects
Primary endpoint: Re-Displacement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of ureteral stone fragments identified
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Change From Baseline in 24-hour Urine Protein to Creatinine Ratio (uPCR) at Week 36
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Total Estimated Glomerular Filtration Rate (eGFR) Slope Through Week 104
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Percentage of Participants Achieving a 75% Reduction in EASI 75 Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Percentage of Participants Achieving vIGA-AD 0 or 1
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Retention rate as measured by the proportion of participants who provide 6 month combined data
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Number of Participants With Adverse Events (AES) and Serious Adverse Events (SAEs)
Endpoint domain: Adverse events/effects
Primary endpoint: Need for intubation and/or mechanical ventilation
Endpoint domain: Adverse events/effects
Primary endpoint: Berg And Balance scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time Up And Go
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: MOCA
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cognitive functioning
Primary endpoint: Gait dynamic index
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Activity specific balance scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Modified Oswestry low back pain questionnaire
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Minimal Residual Disease (MRD) negative Complete Response (CR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Safety and tolerability of MAR001
Endpoint domain: Adverse events/effects
Primary endpoint: Percentage of Participants with SALT Score <= 20
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Number of related Adverse Events
Endpoint domain: Adverse events/effects
Primary endpoint: DLT or the highest dose
Endpoint domain: Adverse events/effects
Primary endpoint: Change in Bleeding on Probing (BOP%)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Gingival Bleeding Index (GBI%)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Frequency of dose limiting toxicity (DLT)
Endpoint domain: Adverse events/effects
Primary endpoint: Short-term CPAP adherence
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Serum hyaluronan levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Insulin sensitivity index (SI)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: UNC Transition Index measure
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Change in the skeletal muscle mass
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in the physical performance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Kessler Psychological Distress Scale (KPDS)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Parent-Child Relationship Scale
Endpoint domain: Life impact
Endpoint subdomain: Social functioning
Primary endpoint: Parental Bonding Inventory (PBI)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Number of Respondents Who Responded YES to Any Question Defining High Risk Penicillin Allergy
Endpoint domain: Adverse events/effects
Primary endpoint: Number of Subjects Who Did Not Have Pre-defined Changes in Vital Signs or Pre-defined Emergence of New Respiratory or Skin Symptoms After Oral Challenge
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Colorectal cancer screening completion rate
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Preoperative Anxiety Level
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Duration taken for serum HCO3 ≥ 15 within 24 hours ICU admission
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Mean difference of serum sodium level between Sterofundin and normal saline
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Mean difference of serum potassium level between Sterofundin and normal saline
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change in scores of the Rating of Everyday Arm-Use in the Community and Home (REACH)
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Change in scores of the Canadian Occupational Performance Measure (COPM)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Change in Percentage of Participants Who Survived
Endpoint domain: Mortality/survival
Primary endpoint: Change in maximum isometric tongue pressure (MIP)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in regular effort saliva swallow pressure (RESS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in effortful swallow pressure (ESP)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Keratometry stability
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pachymetry stability
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Uncorrected visual acuity stability
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Corneal endothelium safety
Endpoint domain: Adverse events/effects
Primary endpoint: Repeatability of 129Xe MRI/MRS Metrics
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Quantitative Analysis of Gas Exchange
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Identification of Active Fibrosis
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Acceptability of the supplement
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Nutritional adequacy
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Proptosis Response Rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in PROMIS-29 Score
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Investigators Global Assessment (IGA)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Blood Cholesterol Level
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Falling Risk
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Frequency and Treatment Adherence Rates
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Change in Voice Handicap Index - 10
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change in Acoustic Analysis of Voice
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of participants who wore the Fitbit device
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Completion of questionnaires
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: APOE Genotype
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction of beta power
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Change in height-Adjusted Total kidney volume
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Change in nicotinic acid levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Sensory and motor function loss
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Number of patients with a consultation
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Time to diagnosis of glenohumeral joint dislocations
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Recovery of SARS-CoV-2 virus remnants
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Adverse Events severity and frequency
Endpoint domain: Adverse events/effects
Primary endpoint: Phenomic features
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Recommended phase II dose (RP2D)
Endpoint domain: Adverse events/effects
Endpoint subdomain: Any subdomain
Primary endpoint: Undetectable minimal residual disease <10-4 (uMRD)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Type, incidence and severity of AEs and serious adverse events (SAEs)
Endpoint domain: Adverse events/effects
Primary endpoint: Length of time to first Bowel Movement (BM)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Length of time to first flatus
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Staging
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Patient management
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Composite outcome of mortality and serious morbidity
Endpoint domain: Mortality/survival
Primary endpoint: Serious morbidity (cardiac events)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Serious morbidity (renal events)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Serious morbidity (neurological events)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: pathologic complete response rates
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Immediate Recall (CAVLT-2/RAVLT)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Change in Working Memory (NIH Toolbox)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Change in Mean Reaction Time (CANTAB)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Quality of digitalized slide
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change from baseline length and diameter of the stenosis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Crohn's disease activity index (CDAI) questionnaire score
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Change in incidence of Contrast Induced Nephropathy (CIN)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Visual Analog pain scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Visual Analog Comfort scale
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Visual Analog Sleep Scale
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: The State-Trait Anxiety Inventory Form (STAI)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: FAI quantification
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Total Plaque Volume
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Patient Health Questionnaire-8 (PHQ8)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Change in pregnancy-related breast cancer (PRBC) score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Rate of CKD diagnosis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Rate of Cardiovascular related Hospitalizations
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: Change in the amount of time in stage three sleep
Endpoint domain: Physiological/clinical
Endpoint subdomain: Sleep
Primary endpoint: Clinical Worsening
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: ED 3-day Readmissions
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: AUECPL
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pregnancy supplementation for 180 days (binary)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Pregnancy and childbirth outcomes
Primary endpoint: Pregnancy supplementation for 180 days (continuous)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Pregnancy and childbirth outcomes
Primary endpoint: Vaccine Effectiveness (VE) of PCV13 Against Hospitalized VT CAP
Endpoint domain: Mortality/survival
Primary endpoint: Percentage change in low-density lipoprotein cholesterol (LDL-C)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Pneumonia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Retained gastric food
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Objective Response Rate
Endpoint domain: Efficacy
Primary endpoint: Physical function (Flexibility)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Hospital-free days within 90 days of randomisation
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: A composite of death from any cause or moderate to severe neurodevelopmental disability
Endpoint domain: Mortality/survival
Primary endpoint: Stigma/discrimination regarding mental disorders
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Number of participants with clinical control of bleeding
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Decrease in gastroparesis-related symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Chron's Disease Activity Index
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Absolute change in percent predicted FEV1 (ppFEV1)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Absolute change in percent predicted FVC (ppFVC)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Molecular subsets quantification
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Sensitivity, specificity, positive predictive value and negative predictive value of remote monitoring-based CRS detection/ prediction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Assessment of neurotoxicity via digital capture of neurological assessment
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Sensitivity, specificity, positive predictive value and negative predictive value of novel digital neurotoxicity tests (BF-Neuro)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Percent change from baseline in whole blood metal-free PPIX levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes in fat mass via bioimpedance analysis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes